Spatial Intelligence Summit: Shaping the Future of Drug Discovery & Development
Hosted by PredxBio
You’re Registered!
Thank you for securing your spot at the
Spatial Intelligence Summit: Shaping the Future of Drug Discovery & Development.
November 5, 2025
8:00 AM EST - 3:00PM EST
The Assembly, 5051 Centre Ave, Pittsburgh, PA 15213, USA
What’s Next?
Check your inbox — a confirmation email with event details is on the way.
Save the date — add the Summit to your calendar.
Outlook® Calendar
|
Google Calendar™
|
iCal®
SHARE ON LINKEDIN — let people know you’re coming.
Plan your visit — watch for upcoming details on travel, lodging, and networking opportunities.
We can’t wait to welcome you to Pittsburgh for a day of science, collaboration, and discovery.
Featured Presenters

Arutha Kulasinghe, PhD
Founding Scientific Director
Queensland Spatial Biology Centre

Tullia Bruno, PhD
Assistant Professor of Immunology University of Pittsburgh School of Medicine

Prasad S. Adusumilli, MD
Vice Chair for Translational Research
Memorial Sloan Kettering Cancer Center

Hoifung Poon, PhD
General Manager
Microsoft Research

Ven Raju
President & CEO
Innovation Works

Carlo Bifulco, MD
Chief Medical Officer
Providence Genomics

Laura Dillon, PhD
Senior Director, Partnership Strategy Lead
AstraZeneca

Samir Hanash, MD, PhD
Director and Distinguished Chair, Clinical Cancer Prevention
MD Anderson Cancer Center

Vipul Baxi, MS, MBA
Executive Director, Computational Imaging and Digital Biomarkers
AMGEN

Davide Bedognetti, MD, PhD
Executive Director, Translational Medicine
Kite Pharma - A Gilead Company

Amanda Poholek, PhD
Associate Professor of Immunology
University of Pittsburgh School of Medicine

Jill Stefanelli, PhD
CEO
Modella AI

Michael Surace, PhD
Director, Cancer Biomarker Development
AstraZeneca

William Mifsud, MD, PhD
Senior Director, Pathology
Kite Pharma - A Gilead Company

S. Chakra Chennubhotla, PhD
Chief of AI, COO, and
Co-Founder
PredxBio

B. Dusty Majumdar, PhD
CEO
PredxBio
AGENDA – NOV 5, 2025
| Time | Session | Presenters |
| 8:00 – 8:25 | Registration & Badge Pickup | — |
| 8:30 – 8:40 | Summit Kickoff |
Dusty Majumdar, PhD (CEO, PredxBio) & Stanley Marks (Chairman, UPMC Hillman Cancer Center) |
| 8:40 – 9:05 |
Shaping the Future of Drug Discovery & Development |
Dusty Majumdar, PhD (PredxBio) |
| 9:05 – 9:30 | Keynote Presentation | Arutha Kulasinghe, PhD (University of Queensland) |
| 9:30 – 9:50 | Spotlight Session | Tullia Bruno, PhD (University of Pittsburgh) |
| 9:50 – 10:05 | Coffee Break | Networking |
| 10:05 – 10:35 | Spotlight Session |
Chakra Chennubhotla, PhD (PredxBio) & Filippo Pullara, PhD (PredxBio) |
| 10:35 – 10:55 | Spotlight Session | Hoifung Poon, PhD (Microsoft Research) |
| 10:55 – 11:15 | Spotlight Session | Carlo Bifulco, MD (Providence Genomics) |
| 11:15 – 11:45 |
Industry Leaders Roundtable: Driving the Future of Drug Discovery |
Moderator: Laura Dillon, PhD (AstraZeneca) Panelists: Davide Bedognetti, MD, PhD (Kite Pharma – A Gilead Company) Vipul Baxi, MS, MBA (Amgen) Jill Stefanelli, PhD (Modella AI) Michael Surace, PhD (AstraZeneca) William Mifsud, MD (Kite Pharma – A Gilead Company) |
| 11:45 – 12:30 | Lunch | Networking |
| 12:30 – 12:50 | Fireside Chat |
Dusty Majumdar, PhD (PredxBio) & Brian McKelligon (Former CEO of Akoya Biosciences) |
| 12:50 – 1:10 | Spotlight Session | Michael Surace, PhD (AstraZeneca) |
| 1:10 – 1:30 | Spotlight Session | Sam Hanash, MD, PhD (MD Anderson Cancer Center) |
| 1:30 – 1:45 | Coffee Break | Desserts & Networking |
| 1:45 – 2:05 | Spotlight Session | Jill Stefanelli, PhD (Modella AI) |
| 2:05 – 2:25 | Spotlight Session | Prasad Adusumalli, MD (Memorial Sloan Kettering Cancer Center) |
| 2:25 – 2:50 |
Fireside Chat: Market Dynamics and Investment Climate |
Ven Raju (Innovation Works), Brianna McDonald (NW Angel Fund), Dave Edwards (WD Investments), & Laura Dillon, PhD (AstraZeneca), with Dusty Majumdar, PhD (PredxBio) |
| 2:50 – 3:10 | Spotlight Session | Amanda Poholek, PhD (University of Pittsburgh) |
| 3:10 – 3:40 |
Looking Ahead: Charting What’s Next |
Arutha Kulasinghe, PhD (University of Queensland), Hoifung Poon, PhD (Microsoft), Brian McKelligon (Former CEO of Akoya Biosciences), & Sam Hanash, MD, PhD (MD Anderson Cancer Center), with Dusty Majumdar, PhD (PredxBio) |
About PredxBio
PredxBio is a global leader in AI-powered spatial biology, transforming complex tissue imaging and multi-modal data into actionable insights. Our proprietary platform enables pharmaceutical companies and research institutions to accelerate drug discovery, optimize clinical trials, and predict patient outcomes with unprecedented precision. By revealing the network biology of cancer, we are setting new standards for biomarker discovery and personalized medicine.





